000			a
999			_c15592 _d15592
003			OSt
005			20211124151122.0
008			211124b xxu||||| |||| 00| 0 eng d
040			_aAIKTC-KRRC _cAIKTC-KRRC
100			_914810 _a Jalagam, Silpa
245			_aOverview on Pharmaceutical Tendering Process
250			_aVol.55(1), Jan-Mar
260			_aBanaglore _bAssociation of Pharmaceutical Teachers of India (APTI) _c2021
300			_a21-25p.
520			_aObjectives: World Health Organization (WHO) has implemented the Pharmaceutical tendering process for procuring the high-quality medicines from different firms to meet the needs of the countries which are having drug shortages. Materials and Methods: The main aim of the WHO is to get the quality products at low price which can be affordable by the patient. WHO constantly giving chance to different firms based on their qualification for tendering process. The pharmaceutical companies are inspected by WHO members to check whether the company is adhering with Good Manufacturing Practices (GMP) regulations and Quality Management system (QMS) requirements. Results: The WHO allows only prequalified pharmaceutical company for the tendering process (Restricted tender). By this process WHO allows the company which produces quality drugs at the affordable cost and complying with the all WHO regulations. Comparing the restricted to open tender, the direct procurement and competitive negotiations tender methods are little disadvantageous as the drugs are taken from highly reputed or single manufacturer which causes the price of the drug to be higher. In the open tender and restricted tender, the WHO can get the manufacturers who supply drug products at low prices.
650		0	_94639 _aPHARMACEUTICS
700			_914811 _aSathyanarayana, Muddukrishna Badamane
773	0		_tIndian journal of pharmaceutical education and research _x0019-5464 _dBengluru Association of Pharmaceutical Teachers of India (APTI)
856			_uhttps://www.ijper.org/sites/default/files/IndJPhaEdRes_55_1_21.pdf _yClick here
942			_2ddc _cAR